Ph2 study of PCS6422 with advanced met breast cancer

Phase II Clinical Trial

A Phase 2 Open-Label Study of PCS6422 with Capecitabine in Patients with Advanced or Metastatic Breast Cancer (PCS6422-BC-01)

Indication: Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer
Trial Number: 06568692
Trial Status: OPEN

Learn more about this clinical trial.

Participating Locations